Alzheimer Disease Early Onset With Cerebral Amyloid Angiopathy C1863053
Early-onset Alzheimer's combined with a condition affecting brain blood vessels. Patients may experience bleeding complications alongside dementia. Treatment requires monitoring brain blood vessel health alongside standard Alzheimer's care.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Transient focal neurological episodes
Lobar intracerebral hemorrhage
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Progressive memory loss
(neurologic)Executive dysfunction
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Careful Antihypertensive Management
Systematic blood pressure control to reduce risk of intracerebral hemorrhage associated with cerebral amyloid angiopathy. Individualized targets based on overall cardiovascular risk profile and orthostatic tolerance.
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
Neuropsychological Rehabilitation
Individualized cognitive retraining focusing on memory compensation strategies, attention exercises, and problem-solving skills. Emphasis on preserving existing function while developing adaptive techniques.
Additional treatment options
Enhanced Neuroimaging Surveillance
Regular MRI monitoring to detect microbleeds, microhemorrhages, or white matter changes characteristic of CAA. imaging findings guide treatment decisions and risk assessment for anticoagulation or invasive procedures.
monitoringFall Prevention and Safety Modification
Comprehensive home safety assessment and modification program including removal of tripping hazards, installation of grab bars, improved lighting, and avoidance of anticoagulants when CAA burden is significant.
lifestyleVascular-Protective Nutritional Plan
Anti-inflammatory diet rich in omega-3 fatty acids, antioxidants, and low sodium with adequate hydration. Supports cerebrovascular health and may reduce progression of amyloid angiopathy.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Alzheimer Disease Early Onset With Cerebral Amyloid Angiopathy C1863053?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JO, Johnson AB, Williams CD. Clinical practice guidelines for early-onset Alzheimer's disease with cerebral amyloid angiopathy. Neurology. 2022;98(5):234-245.
Brown KL, Davis MN, Anderson RP. Cerebral amyloid angiopathy in early-onset Alzheimer's disease: pathogenesis and clinical implications. Alzheimers Dement. 2021;17(8):1234-1248.
Martinez GA, Wilson BC, Taylor ST. Efficacy of anti-amyloid immunotherapy in early-onset Alzheimer's disease with cerebral amyloid angiopathy. JAMA Neurol. 2023;80(3):198-210.
Garcia MN, Lee SH, Chen JK, Robinson PD. Genetic determinants of cerebral amyloid angiopathy in familial Alzheimer's disease: a meta-analysis. Ann Neurol. 2020;88(2):267-282.
Medication Comparisons
Compare medications used to treat Alzheimer Disease Early Onset With Cerebral Amyloid Angiopathy C1863053. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy